Evaluation of the Efficacy of Sugammadex Based on Ideal Body Weight of Obstetric Patients with Different Groups of Body Mass Indexes

Not Applicable

Completed

• Conditions: obesity; pregnancy; Anaesthesiology - Anaesthetics; Surgery - Other surgery; Diet and Nutrition - Obesity; Reproductive Health and Childbirth - Normal pregnancy

• Registration Number: ACTRN12618001633279
• Lead Sponsor: Basak ALTIPARMAK

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-10-03
• Study Completion: 2018-12-21
• Last Update Posted: 28 January 2019

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 90

Inclusion Criteria

The patients over 18 years old with ASA status II and scheduled for an elective caesarean section under general anesthesia

Exclusion Criteria

presence of pulmonary diseases (asthma, chronic obstructive pulmonary disease etc), known allergy to study drugs, use of medications that can affect neuromuscular blockade such as magnesium sulphate, anticonvulsive drugs, macrolids and aminoglycosides, decline participation to the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total sugammadex dose applied to each patient by directly calculating from data-linkage to medical records [At the end of the surgery ]

Secondary Outcome Measures

Name	Time	Method
Duration between the first dose of sugammadex and successful extubation as assessed by stopwatch. [At the end of the surgery ];Duration between the first dose of sugammadex and motor response to commands as assessed by stopwatch. [At the end of the surgery ];Duration between the end of surgery and first breast feeding as assessed by data-linkage to medical records[First breast feeding time with a maximum observation period of postoperative first 24 hours. ]